Biden admin allocates $5 billion for new COVID vaccines with little manufacturing guidance
(Worthy News) – The Biden administration is issuing grants from a $5 billion program to expedite the next generation of COVID-19 vaccines, but pharmaceutical manufacturers are not receiving guidance about vaccine standards as the development process returns to its normally slower pace.
The initiative, known as Project NextGen, has left manufacturers confused about whether they are even eligible for funding, The New York Times reported.
For example, the Pennsylvania-based company Ocugen, which is developing an inhaled vaccine, said it was unable to receive guidance about whether it was eligible for the funding. The company said its vaccine may not have undergone enough advanced testing to qualify for the grants. [ Source (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌